Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 106941-25-7
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
106941-25-7 |
Appearance:: |
White To Off-white Powder |
Molecular Formula:: |
C8H12N5O4P |
Molecular Weight:: |
273.18600 |
EINECS NO:: |
600-789-7 |
MDL NO:: |
MFCD00866943 |
CAS NO:: |
106941-25-7 |
Appearance:: |
White To Off-white Powder |
Molecular Formula:: |
C8H12N5O4P |
Molecular Weight:: |
273.18600 |
EINECS NO:: |
600-789-7 |
MDL NO:: |
MFCD00866943 |
Product Description:
Product Name: Adefovir CAS NO: 106941-25-7
Synonyms:
treatment Adefovir;
Tenofovir Desmeth-yl Impurity;
2-(6-amino-9h-purin-;Adefovir dipivox (PMEA);
Chemical & Physical Properties:
Appearance: White to off-white powder
Assay :≥99.0%
Density: 1.88
Boiling Point: 632.5℃ at 760 mmHg
Melting Point: >260℃
Flash Point: 336.3℃
Safety Information:
Hazard Class: 8
Safety Statement: S26
HS Code: 2933990090
WGK Germany: 2
Packing Group: III
RIDADR: UN 2585 8/PG 3
Risk Statements: R36/37/38
Hazard Code: Xi
Hazard Declaration: H301
Symbol: GHS06
Caution Statements: P301 + P310
Signal Word: Danger
Adefovir (Trade name: Preveon, Hepsera) is a prescription drug used for the treatment of chronic infections of hepatitis B virus. It can be formulated as the pivoxil prodrug adefovir dipivoxil. However, it shows no effect against HIV-1. As a orally administrated acyclic nucleotide analog reverse transcriptase inhibitor, it blocking the reproduction of HBV through inhibiting the reverse transcriptase in the body. One of its advantages over another anti-HBV drug, lamivudine is that it is much harder for the virus to develop resistance to it.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.